耐药性延迟发病的氨酸诱导血小板缩 (HIT) 没有血栓形成,用静脉注射免疫球蛋白治疗
Gordana Tomac1, Ivona Horvat1, Jakša Babel2
1Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.
概括
耐火性延迟发病的肝素诱导血小板缺血 (HIT) 是罕见的,但具有挑战性. 静脉注射免疫球蛋白 (IVIG) 成功治疗了患有长期血小板缺血症的患者,突出了早期识别和管理这种HIT变体的必要性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 氨酸诱导的血小板缺血 (HIT) 是氨酸治疗的免疫媒介并发症.
- 迟发性HIT和耐火性HIT是罕见的变体,具有诊断和治疗方面的挑战.
- 耐火性迟发性HIT可能会导致长期的发病率,如果没有及时干预.
研究的目的:
- 报告一名69岁男性耐火性延迟发作的HIT病例.
- 为了突出诊断确认,使用功能性测试检测抗PF4/氨酸抗体.
- 为了证明耐火性迟发性HIT与静脉注射免疫球蛋白 (IVIG) 的成功治疗.
主要方法:
- 一个患有耐火性延迟发作HIT的患者的病例报告介绍.
- 通过功能性测定,通过血小板激活抗PF4/氨酸抗体来确认诊断.
- 用静脉注射免疫球蛋白 (IVIG) 治疗长期的血小板缺血症.
主要成果:
- 这位患者出现了长期的血栓细胞减小,而没有发生血栓形成.
- 耐火性延迟发作的HIT的诊断通过实验室测试得到证实.
- 通过IVIG治疗,成功恢复了血小板数量.
结论:
- 耐火性延迟发作的HIT是一种临床上显著的实体,需要迅速识别.
- 功能性测试对于诊断HIT变体至关重要.
- IVIG可以作为耐火性延迟发作的HIT的有效治疗方法,改善血小板数量的恢复.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
548
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
548
Immunoprecipitation
5.1K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.1K


